“…While the currently open and pending trials vary in terms of patient inclusion criteria and in how APBI is delivered, we expect that they will provide definitive information on whether APBI provides comparable local control and toxicity outcomes as WBI. In the interim, investigators are attempting to answer new questions regarding APBI, such as whether MRI can be used to better define patients who can be treated with APBI, brachytherapy‐based APBI can be delivered with fewer total fractions, or APBI should be delivered in the preoperative setting .…”